img

Global and United States Hepatic Encephalopathy Treatment Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Hepatic Encephalopathy Treatment Market Report & Forecast 2024-2034

Hepatic encephalopathy (HE) treatment aims to manage the symptoms and underlying causes of the condition. HE is a condition where the liver is unable to remove toxins from the bloodstream effectively, leading to a buildup of toxins in the brain. The condition can range from mild to severe, with symptoms such as confusion, personality changes, tremors, and even coma.
Market Analysis and InsightsGlobal and United States Hepatic Encephalopathy Treatment Market
This report focuses on global and United States Hepatic Encephalopathy Treatment market, also covers the segmentation data of other regions in regional level and county level.
The global Hepatic Encephalopathy Treatment revenue was US$ 1486 million in 2024 and is forecast to a readjusted size of US$ 2309.8 million by 2034 with a CAGR of 6.5% during the forecast period (2024-2034).
In United States the Hepatic Encephalopathy Treatment revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Hepatic Encephalopathy Treatment include Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services and Takeda Pharmaceutical Company Limited, etc. The global five biggest players hold a share of % in 2024.
Global Hepatic Encephalopathy Treatment Scope and Market Size
Hepatic Encephalopathy Treatment market is segmented in regional and country, by players, by route and by application. Companies, stakeholders, and other participants in the global Hepatic Encephalopathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by route and by application for the period 2018-2034.
For United States market, this report focuses on the Hepatic Encephalopathy Treatment market size by players, by Route and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Mallinckrodt Pharmaceuticals
Salix Pharmaceuticals
GlaxoSmithKline plc.
Pfizer Inc.
ASKA Pharmaceutical Co., Ltd.
Bausch Health
Johnson & Johnson Services, Inc.
Janssen Global Services
Takeda Pharmaceutical Company Limited
Merck & Co., Inc.
Segment by Route
Oral
Injectable

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Hepatic Encephalopathy Treatment definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by route, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Hepatic Encephalopathy Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Hepatic Encephalopathy Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by route, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by route, by application and by region, sales, and revenue for each segment.
Chapter 8China by route, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by route, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatic Encephalopathy Treatment sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Hepatic Encephalopathy Treatment Product Introduction
1.2 Global Hepatic Encephalopathy Treatment Outlook 2018 VS 2024 VS 2034
1.2.1 Global Hepatic Encephalopathy Treatment Sales in US$ Million for the Year 2018-2034
1.2.2 Global Hepatic Encephalopathy Treatment Sales in Volume for the Year 2018-2034
1.3 United States Hepatic Encephalopathy Treatment Outlook 2018 VS 2024 VS 2034
1.3.1 United States Hepatic Encephalopathy Treatment Sales in US$ Million for the Year 2018-2034
1.3.2 United States Hepatic Encephalopathy Treatment Sales in Volume for the Year 2018-2034
1.4 Hepatic Encephalopathy Treatment Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Hepatic Encephalopathy Treatment in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Hepatic Encephalopathy Treatment Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Hepatic Encephalopathy Treatment Market Dynamics
1.5.1 Hepatic Encephalopathy Treatment Industry Trends
1.5.2 Hepatic Encephalopathy Treatment Market Drivers
1.5.3 Hepatic Encephalopathy Treatment Market Challenges
1.5.4 Hepatic Encephalopathy Treatment Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Hepatic Encephalopathy Treatment by Route
2.1 Hepatic Encephalopathy Treatment Market Segment by Route
2.1.1 Oral
2.1.2 Injectable
2.2 Global Hepatic Encephalopathy Treatment Market Size by Route
2.2.1 Global Hepatic Encephalopathy Treatment Sales in Value, by Route (2018, 2024 & 2034)
2.2.2 Global Hepatic Encephalopathy Treatment Sales in Volume, by Route (2018, 2024 & 2034)
2.2.3 Global Hepatic Encephalopathy Treatment Average Selling Price (ASP) by Route (2018, 2024 & 2034)
2.3 United States Hepatic Encephalopathy Treatment Market Size by Route
2.3.1 United States Hepatic Encephalopathy Treatment Sales in Value, by Route (2018, 2024 & 2034)
2.3.2 United States Hepatic Encephalopathy Treatment Sales in Volume, by Route (2018, 2024 & 2034)
2.3.3 United States Hepatic Encephalopathy Treatment Average Selling Price (ASP) by Route (2018, 2024 & 2034)
3 Hepatic Encephalopathy Treatment by Application
3.1 Hepatic Encephalopathy Treatment Market Segment by Application
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.2 Global Hepatic Encephalopathy Treatment Market Size by Application
3.2.1 Global Hepatic Encephalopathy Treatment Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Hepatic Encephalopathy Treatment Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Hepatic Encephalopathy Treatment Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Hepatic Encephalopathy Treatment Market Size by Application
3.3.1 United States Hepatic Encephalopathy Treatment Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Hepatic Encephalopathy Treatment Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Hepatic Encephalopathy Treatment Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Hepatic Encephalopathy Treatment Competitor Landscape by Company
4.1 Global Hepatic Encephalopathy Treatment Market Size by Company
4.1.1 Global Key Manufacturers of Hepatic Encephalopathy Treatment, Ranked by Revenue (2024)
4.1.2 Global Hepatic Encephalopathy Treatment Revenue by Manufacturer (2018-2023)
4.1.3 Global Hepatic Encephalopathy Treatment Sales by Manufacturer (2018-2023)
4.1.4 Global Hepatic Encephalopathy Treatment Price by Manufacturer (2018-2023)
4.2 Global Hepatic Encephalopathy Treatment Concentration Ratio (CR)
4.2.1 Hepatic Encephalopathy Treatment Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hepatic Encephalopathy Treatment in 2024
4.2.3 Global Hepatic Encephalopathy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Hepatic Encephalopathy Treatment, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Hepatic Encephalopathy Treatment, Product Offered and Application
4.5 Global Key Manufacturers of Hepatic Encephalopathy Treatment, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Hepatic Encephalopathy Treatment Market Size by Company
4.7.1 Key Players of Hepatic Encephalopathy Treatment in United States, Ranked by Revenue (2024)
4.7.2 United States Hepatic Encephalopathy Treatment Revenue by Players (2018-2023)
4.7.3 United States Hepatic Encephalopathy Treatment Sales by Players (2018-2023)
5 Global Hepatic Encephalopathy Treatment Market Size by Region
5.1 Global Hepatic Encephalopathy Treatment Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Hepatic Encephalopathy Treatment Market Size in Volume by Region (2018-2034)
5.2.1 Global Hepatic Encephalopathy Treatment Sales in Volume by Region: 2018-2023
5.2.2 Global Hepatic Encephalopathy Treatment Sales in Volume Forecast by Region (2024-2034)
5.3 Global Hepatic Encephalopathy Treatment Market Size in Value by Region (2018-2034)
5.3.1 Global Hepatic Encephalopathy Treatment Sales in Value by Region: 2018-2023
5.3.2 Global Hepatic Encephalopathy Treatment Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Hepatic Encephalopathy Treatment Market Size YoY Growth 2018-2034
6.2 Americas Hepatic Encephalopathy Treatment Sales in Volume, by Route (2018, 2024 & 2034)
6.3 Americas Hepatic Encephalopathy Treatment Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Hepatic Encephalopathy Treatment Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Hepatic Encephalopathy Treatment Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Hepatic Encephalopathy Treatment Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Hepatic Encephalopathy Treatment Market Size YoY Growth 2018-2034
7.2 EMEA Hepatic Encephalopathy Treatment Sales in Volume, by Route (2018, 2024 & 2034)
7.3 EMEA Hepatic Encephalopathy Treatment Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Hepatic Encephalopathy Treatment Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Hepatic Encephalopathy Treatment Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Hepatic Encephalopathy Treatment Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Hepatic Encephalopathy Treatment Market Size YoY Growth 2018-2034
8.2 China Hepatic Encephalopathy Treatment Sales in Volume, by Route (2018, 2024 & 2034)
8.3 China Hepatic Encephalopathy Treatment Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Hepatic Encephalopathy Treatment Market Size YoY Growth 2018-2034
9.2 APAC Hepatic Encephalopathy Treatment Sales in Volume, by Route (2018, 2024 & 2034)
9.3 APAC Hepatic Encephalopathy Treatment Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Hepatic Encephalopathy Treatment Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Hepatic Encephalopathy Treatment Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Hepatic Encephalopathy Treatment Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Mallinckrodt Pharmaceuticals
10.1.1 Mallinckrodt Pharmaceuticals Company Information
10.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
10.1.3 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Products Offered
10.1.5 Mallinckrodt Pharmaceuticals Recent Development
10.2 Salix Pharmaceuticals
10.2.1 Salix Pharmaceuticals Company Information
10.2.2 Salix Pharmaceuticals Description and Business Overview
10.2.3 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Products Offered
10.2.5 Salix Pharmaceuticals Recent Development
10.3 GlaxoSmithKline plc.
10.3.1 GlaxoSmithKline plc. Company Information
10.3.2 GlaxoSmithKline plc. Description and Business Overview
10.3.3 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Products Offered
10.3.5 GlaxoSmithKline plc. Recent Development
10.4 Pfizer Inc.
10.4.1 Pfizer Inc. Company Information
10.4.2 Pfizer Inc. Description and Business Overview
10.4.3 Pfizer Inc. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Inc. Hepatic Encephalopathy Treatment Products Offered
10.4.5 Pfizer Inc. Recent Development
10.5 ASKA Pharmaceutical Co., Ltd.
10.5.1 ASKA Pharmaceutical Co., Ltd. Company Information
10.5.2 ASKA Pharmaceutical Co., Ltd. Description and Business Overview
10.5.3 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.5.4 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Products Offered
10.5.5 ASKA Pharmaceutical Co., Ltd. Recent Development
10.6 Bausch Health
10.6.1 Bausch Health Company Information
10.6.2 Bausch Health Description and Business Overview
10.6.3 Bausch Health Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bausch Health Hepatic Encephalopathy Treatment Products Offered
10.6.5 Bausch Health Recent Development
10.7 Johnson & Johnson Services, Inc.
10.7.1 Johnson & Johnson Services, Inc. Company Information
10.7.2 Johnson & Johnson Services, Inc. Description and Business Overview
10.7.3 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Products Offered
10.7.5 Johnson & Johnson Services, Inc. Recent Development
10.8 Janssen Global Services
10.8.1 Janssen Global Services Company Information
10.8.2 Janssen Global Services Description and Business Overview
10.8.3 Janssen Global Services Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Janssen Global Services Hepatic Encephalopathy Treatment Products Offered
10.8.5 Janssen Global Services Recent Development
10.9 Takeda Pharmaceutical Company Limited
10.9.1 Takeda Pharmaceutical Company Limited Company Information
10.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview
10.9.3 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Products Offered
10.9.5 Takeda Pharmaceutical Company Limited Recent Development
10.10 Merck & Co., Inc.
10.10.1 Merck & Co., Inc. Company Information
10.10.2 Merck & Co., Inc. Description and Business Overview
10.10.3 Merck & Co., Inc. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Merck & Co., Inc. Hepatic Encephalopathy Treatment Products Offered
10.10.5 Merck & Co., Inc. Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Hepatic Encephalopathy Treatment Industry Chain Analysis
11.2 Hepatic Encephalopathy Treatment Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Hepatic Encephalopathy Treatment Production Mode & Process
11.4 Hepatic Encephalopathy Treatment Sales and Marketing
11.4.1 Hepatic Encephalopathy Treatment Sales Channels
11.4.2 Hepatic Encephalopathy Treatment Distributors
11.5 Hepatic Encephalopathy Treatment Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Hepatic Encephalopathy Treatment CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Hepatic Encephalopathy Treatment Market Trends
Table 3. Hepatic Encephalopathy Treatment Market Drivers
Table 4. Hepatic Encephalopathy Treatment Market Challenges
Table 5. Hepatic Encephalopathy Treatment Market Restraints
Table 6. Global Hepatic Encephalopathy Treatment Sales Growth Rate (CAGR) by Route: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Hepatic Encephalopathy Treatment Sales Growth Rate (CAGR) by Route: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Hepatic Encephalopathy Treatment Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Hepatic Encephalopathy Treatment Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Hepatic Encephalopathy Treatment, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Hepatic Encephalopathy Treatment Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Hepatic Encephalopathy Treatment Revenue Share by Manufacturer, 2018-2023
Table 13. Global Hepatic Encephalopathy Treatment Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Hepatic Encephalopathy Treatment Sales Share by Manufacturer, 2018-2023
Table 15. Global Hepatic Encephalopathy Treatment Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Hepatic Encephalopathy Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hepatic Encephalopathy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatic Encephalopathy Treatment as of 2024)
Table 18. Global Key Manufacturers of Hepatic Encephalopathy Treatment, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Hepatic Encephalopathy Treatment, Product Offered and Application
Table 20. Global Key Manufacturers of Hepatic Encephalopathy Treatment, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Hepatic Encephalopathy Treatment in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Hepatic Encephalopathy Treatment Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Hepatic Encephalopathy Treatment Revenue Share by Players, (2018-2023)
Table 25. United States Hepatic Encephalopathy Treatment Sales by Players, (K Units), (2018-2023)
Table 26. United States Hepatic Encephalopathy Treatment Sales Share by Players, (2018-2023)
Table 27. Global Hepatic Encephalopathy Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Hepatic Encephalopathy Treatment Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Hepatic Encephalopathy Treatment Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Hepatic Encephalopathy Treatment Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Hepatic Encephalopathy Treatment Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Hepatic Encephalopathy Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Hepatic Encephalopathy Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Hepatic Encephalopathy Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Hepatic Encephalopathy Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Hepatic Encephalopathy Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Hepatic Encephalopathy Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Hepatic Encephalopathy Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Hepatic Encephalopathy Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Hepatic Encephalopathy Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Hepatic Encephalopathy Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Hepatic Encephalopathy Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Hepatic Encephalopathy Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Hepatic Encephalopathy Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Hepatic Encephalopathy Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Hepatic Encephalopathy Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Mallinckrodt Pharmaceuticals Company Information
Table 48. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 49. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product
Table 51. Mallinckrodt Pharmaceuticals Recent Development
Table 52. Salix Pharmaceuticals Company Information
Table 53. Salix Pharmaceuticals Description and Business Overview
Table 54. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product
Table 56. Salix Pharmaceuticals Recent Development
Table 57. GlaxoSmithKline plc. Company Information
Table 58. GlaxoSmithKline plc. Description and Business Overview
Table 59. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product
Table 61. GlaxoSmithKline plc. Recent Development
Table 62. Pfizer Inc. Company Information
Table 63. Pfizer Inc. Description and Business Overview
Table 64. Pfizer Inc. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Pfizer Inc. Hepatic Encephalopathy Treatment Product
Table 66. Pfizer Inc. Recent Development
Table 67. ASKA Pharmaceutical Co., Ltd. Company Information
Table 68. ASKA Pharmaceutical Co., Ltd. Description and Business Overview
Table 69. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product
Table 71. ASKA Pharmaceutical Co., Ltd. Recent Development
Table 72. Bausch Health Company Information
Table 73. Bausch Health Description and Business Overview
Table 74. Bausch Health Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Bausch Health Hepatic Encephalopathy Treatment Product
Table 76. Bausch Health Recent Development
Table 77. Johnson & Johnson Services, Inc. Company Information
Table 78. Johnson & Johnson Services, Inc. Description and Business Overview
Table 79. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product
Table 81. Johnson & Johnson Services, Inc. Recent Development
Table 82. Janssen Global Services Company Information
Table 83. Janssen Global Services Description and Business Overview
Table 84. Janssen Global Services Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Janssen Global Services Hepatic Encephalopathy Treatment Product
Table 86. Janssen Global Services Recent Development
Table 87. Takeda Pharmaceutical Company Limited Company Information
Table 88. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 89. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product
Table 91. Takeda Pharmaceutical Company Limited Recent Development
Table 92. Merck & Co., Inc. Company Information
Table 93. Merck & Co., Inc. Description and Business Overview
Table 94. Merck & Co., Inc. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Merck & Co., Inc. Hepatic Encephalopathy Treatment Product
Table 96. Merck & Co., Inc. Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Hepatic Encephalopathy Treatment Customers List
Table 100. Hepatic Encephalopathy Treatment Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatic Encephalopathy Treatment Product Picture
Figure 2. Global Hepatic Encephalopathy Treatment Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Hepatic Encephalopathy Treatment Market Size 2018-2034 (US$ Million)
Figure 4. Global Hepatic Encephalopathy Treatment Sales 2018-2034 (K Units)
Figure 5. United States Hepatic Encephalopathy Treatment Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Hepatic Encephalopathy Treatment Market Size 2018-2034 (US$ Million)
Figure 7. United States Hepatic Encephalopathy Treatment Sales 2018-2034 (K Units)
Figure 8. United States Hepatic Encephalopathy Treatment Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Hepatic Encephalopathy Treatment Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Hepatic Encephalopathy Treatment Report Years Considered
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injectable
Figure 13. Global Hepatic Encephalopathy Treatment Market Share by Route in 2024 & 2034
Figure 14. Global Hepatic Encephalopathy Treatment Sales in Value by Route (2018-2034) & (US$ Million)
Figure 15. Global Hepatic Encephalopathy Treatment Sales Market Share in Value by Route (2018-2034)
Figure 16. Global Hepatic Encephalopathy Treatment Sales by Route (2018-2034) & (K Units)
Figure 17. Global Hepatic Encephalopathy Treatment Sales Market Share in Volume by Route (2018-2034)
Figure 18. Global Hepatic Encephalopathy Treatment Price by Route (2018-2034) & (US$/Unit)
Figure 19. United States Hepatic Encephalopathy Treatment Market Share by Route in 2024 & 2034
Figure 20. United States Hepatic Encephalopathy Treatment Sales in Value by Route (2018-2034) & (US$ Million)
Figure 21. United States Hepatic Encephalopathy Treatment Sales Market Share in Value by Route (2018-2034)
Figure 22. United States Hepatic Encephalopathy Treatment Sales by Route (2018-2034) & (K Units)
Figure 23. United States Hepatic Encephalopathy Treatment Sales Market Share in Volume by Route (2018-2034)
Figure 24. United States Hepatic Encephalopathy Treatment Price by Route (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Hospital Pharmacy
Figure 26. Product Picture of Retail Pharmacy
Figure 27. Product Picture of Online Pharmacy
Figure 28. Global Hepatic Encephalopathy Treatment Market Share by Application in 2024 & 2034
Figure 29. Global Hepatic Encephalopathy Treatment Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Hepatic Encephalopathy Treatment Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Hepatic Encephalopathy Treatment Sales by Application (2018-2034) & (K Units)
Figure 32. Global Hepatic Encephalopathy Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Hepatic Encephalopathy Treatment Price by Application (2018-2034) & (US$/Unit)
Figure 34. United States Hepatic Encephalopathy Treatment Market Share by Application in 2024 & 2034
Figure 35. United States Hepatic Encephalopathy Treatment Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. United States Hepatic Encephalopathy Treatment Sales Market Share in Value by Application (2018-2034)
Figure 37. United States Hepatic Encephalopathy Treatment Sales by Application (2018-2034) & (K Units)
Figure 38. United States Hepatic Encephalopathy Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 39. United States Hepatic Encephalopathy Treatment Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Hepatic Encephalopathy Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Hepatic Encephalopathy Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Hepatic Encephalopathy Treatment Sales by Route (2018-2034) & (K Units)
Figure 43. Americas Hepatic Encephalopathy Treatment Sales Market Share in Volume by Route (2018-2034)
Figure 44. Americas Hepatic Encephalopathy Treatment Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Hepatic Encephalopathy Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Hepatic Encephalopathy Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Hepatic Encephalopathy Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Hepatic Encephalopathy Treatment Sales by Route (2018-2034) & (K Units)
Figure 53. EMEA Hepatic Encephalopathy Treatment Sales Market Share in Volume by Route (2018-2034)
Figure 54. EMEA Hepatic Encephalopathy Treatment Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Hepatic Encephalopathy Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Hepatic Encephalopathy Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Hepatic Encephalopathy Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Hepatic Encephalopathy Treatment Sales by Route (2018-2034) & (K Units)
Figure 62. China Hepatic Encephalopathy Treatment Sales Market Share in Volume by Route (2018-2034)
Figure 63. China Hepatic Encephalopathy Treatment Sales by Application (2018-2034) & (K Units)
Figure 64. China Hepatic Encephalopathy Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Hepatic Encephalopathy Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Hepatic Encephalopathy Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Hepatic Encephalopathy Treatment Sales by Route (2018-2034) & (K Units)
Figure 68. APAC Hepatic Encephalopathy Treatment Sales Market Share in Volume by Route (2018-2034)
Figure 69. APAC Hepatic Encephalopathy Treatment Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Hepatic Encephalopathy Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Hepatic Encephalopathy Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Hepatic Encephalopathy Treatment Value Chain
Figure 77. Hepatic Encephalopathy Treatment Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries